According to the Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, along with AstraZeneca and R-Pharm, the two vaccines combined have shown promising immunogenicity results.

According to the Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, along with AstraZeneca and R-Pharm, the two vaccines combined have shown promising immunogenicity results.